Inventor

BIGNAN GILLES C

US7 patents

⚠️ This page may combine multiple inventors who share the name “BIGNAN GILLES C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

4 patents

US7579356B2Aug 25, 2009

Thia-tetraazaacenaphthylene kinase inhibitors

JANSSEN PHARMACEUTICA NV9 citations80

US7655670B2Feb 2, 2010

3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators

JANSSEN PHARMACEUTICA NV8 citations78

US10077261B2Sep 18, 2018

Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer

JANSSEN PHARMACEUTICA NV7 citations70

US8367825B2Feb 5, 2013

Substituted pyrimidinyl oxime kinase inhibitors

JANSSEN PHARMACEUTICA NV0 citations46

XU GUOZHANG

1 patent

US8153791B2Apr 10, 2012

Substituted pyrimidinyl oxime kinase inhibitors

XU GUOZHANG5 citations54

GAUL MICHAEL

1 patent

US8580832B2Nov 12, 2013

Substituted phenoxy aminothiazolones as estrogen related receptor-α modulators

GAUL MICHAEL1 citations47

BIGNAN GILLES C

1 patent

US8741916B2Jun 3, 2014

1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the ORL-1 receptor

BIGNAN GILLES C0 citations26